Perrigo Company plc Public Float
Perrigo Company plc (PRGO) had Public Float of $3.65 billion as of 2025-06-27, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-27: Entity Public Float $3.65B.
- 2024-06-28: Entity Public Float $3.50B.
- 2023-07-01: Entity Public Float $4.60B.
- 2022-07-02: Entity Public Float $5.52B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-27 | $3.65B 10-K · filed 2026-02-26 | |
| 2024-06-28 | $3.50B 10-K · filed 2025-02-28 | |
| 2023-07-01 | $4.60B 10-K · filed 2024-02-27 | |
| 2022-07-02 | $5.52B 10-K · filed 2023-02-28 | |
| 2021-07-03 | $6.27B 10-K · filed 2022-03-01 | |
| 2020-06-26 | $7.36B 10-K · filed 2021-03-01 | |
| 2019-06-28 | $6.48B 10-K · filed 2020-02-27 | |
| 2018-06-29 | $10.03B 10-K · filed 2019-02-27 | |
| 2017-06-30 | $10.77B 10-K · filed 2018-03-01 | |
| 2015-12-31 | $13.05B 10-K · filed 2017-05-22 | $20.71B 10-KT · filed 2016-02-25 |
| 2013-12-27 | $23.37B 10-K · filed 2015-08-13 | $20.34B 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |